Home-Based Photobiomodulation Shows Promise for Dementia Care

Highlights

  • Home-based PBM improved cognition and behavior in patients with dementia.
  • Cerebral perfusion and functional connectivity increased.
  • The protocol combined transcranial and intranasal PBM.
  • Treatments were well tolerated with no adverse effects.
  • PBM may be a practical adjunct for dementia management.

 

Background

Accessible, non-invasive therapies are increasingly needed to support cognitive and behavioral function in dementia. Home-based PBM offers a practical approach for long-term care settings.

Intervention Protocol

Participants received PBM at home:

  • Wavelength: 810 nm
  • Pulse frequency: 40 Hz
  • Session duration: 20 minutes
  • Frequency: 3 sessions per week
  • Duration: 12 weeks
  • Total energy per session: 240 J


Applications combined transcranial and intranasal light delivery.

 

Key Findings

  • Cognitive scores (ADAS-cog) improved in the PBM group, while declining in usual-care controls.
  • Behavioral symptoms (NPI) improved significantly.
  • Enhanced connectivity within default mode network regions was observed.
  • No adverse effects were reported.

 

 

Takeaway

Home-based transcranial and intranasal photobiomodulation may provide a safe, feasible, and supportive intervention for cognitive and behavioral symptoms in dementia. Further controlled trials are needed to confirm these findings.

 

Reference: Chao LL. Effects of Home Photobiomodulation Treatments on Cognitive and Behavioral Function, Cerebral Perfusion, and Resting-State Functional Connectivity in Patients with Dementia: A Pilot Trial. Photobiomodul Photomed Laser Surg. 2019; 37(3):133-141. doi: 10.1089/photob.2018.4555